Literature DB >> 9785671

T-cell anergy and altered T-cell receptor signaling: effects on autoimmune disease.

K V Salojin1, J Zhang, J Madrenas, T L Delovitch.   

Abstract

Immunological self-tolerance can be acquired by several mechanisms, including the induction of anergy in autoreactive T cells. In this sense, anergy is predictably advantageous for the immune system. Here, Konstantin Salojin and colleagues present an alternative view that the induction of anergy in regulatory T cells may be harmful to the host and elicit autoimmune disease.

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9785671     DOI： 10.1016/s0167-5699(98)01326-7

Source DB:  PubMed          Journal:  Immunol Today        ISSN： 0167-5699


  14 in total

1.  Effect of redox balance alterations on cellular localization of LAT and downstream T-cell receptor signaling pathways.

Authors:  Sonja I Gringhuis; Ellen A M Papendrecht-van der Voort; Angela Leow; E W Nivine Levarht; Ferdinand C Breedveld; Cornelis L Verweij
Journal:  Mol Cell Biol       Date:  2002-01       Impact factor: 4.272

2.  Discovery of a novel series of inhibitors of lymphoid tyrosine phosphatase with activity in human T cells.

Authors:  Stephanie M Stanford; Divya Krishnamurthy; Matthew D Falk; Rossella Messina; Bikash Debnath; Sheng Li; Tong Liu; Roza Kazemi; Russell Dahl; Yantao He; Xiao Yu; Andrew C Chan; Zhong-Yin Zhang; Amy M Barrios; Virgil L Woods; Nouri Neamati; Nunzio Bottini
Journal:  J Med Chem       Date:  2011-02-22       Impact factor: 7.446

3.  Induction of T-cell activation or anergy determined by the combination of intensity and duration of T-cell receptor stimulation, and sequential induction in an individual cell.

Authors:  Tomohiro Yamamoto; Makoto Hattori; Tadashi Yoshida
Journal:  Immunology       Date:  2007-03-22       Impact factor: 7.397

4.  T-cell receptor-mediated anergy of a human immunodeficiency virus (HIV) gp120-specific CD4(+) cytotoxic T-cell clone, induced by a natural HIV type 1 variant peptide.

Authors:  L Bouhdoud; P Villain; A Merzouki; M Arella; C Couture
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

5.  Interleukin-15 up-regulates the expression of CD154 on synovial fluid T cells.

Authors:  M Möttönen; P Isomäki; R Luukkainen; P Toivanen; J Punnonen; O Lassila
Journal:  Immunology       Date:  2000-06       Impact factor: 7.397

6.  Altered lipid raft-associated signaling and ganglioside expression in T lymphocytes from patients with systemic lupus erythematosus.

Authors:  Elizabeth C Jury; Panagiotis S Kabouridis; Fabian Flores-Borja; Rizgar A Mageed; David A Isenberg
Journal:  J Clin Invest       Date:  2004-04       Impact factor: 14.808

7.  In vivo islet protection by a nuclear import inhibitor in a mouse model of type 1 diabetes.

Authors:  Daniel J Moore; Jozef Zienkiewicz; Peggy L Kendall; Danya Liu; Xueyan Liu; Ruth Ann Veach; Robert D Collins; Jacek Hawiger
Journal:  PLoS One       Date:  2010-10-06       Impact factor: 3.240

8.  Defective expression and tyrosine phosphorylation of the T cell receptor zeta chain in peripheral blood T cells from systemic lupus erythematosus patients.

Authors:  M Pang; Y Setoyama; K Tsuzaka; K Yoshimoto; K Amano; T Abe; T Takeuchi
Journal:  Clin Exp Immunol       Date:  2002-07       Impact factor: 4.330

Review 9.  Oral tolerance.

Authors:  Henry Yim Wu; Howard L Weiner
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

10.  Neutralization of interleukin-16 protects nonobese diabetic mice from autoimmune type 1 diabetes by a CCL4-dependent mechanism.

Authors:  Craig Meagher; Josh Beilke; Guillermo Arreaza; Qing-Sheng Mi; Wei Chen; Konstantin Salojin; Noah Horst; William W Cruikshank; Terry L Delovitch
Journal:  Diabetes       Date:  2010-08-06       Impact factor: 9.461
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.